Analysis of information sources in references of the Wikipedia article "幼年特發性關節炎" in Chinese language version.
Arthritis affects approximately one child in every 1,000 in a given year. Fortunately, most of these cases are mild. However, approximately one child in every 10,000 will have more severe arthritis that doesn't just go away.
From a doctor's point of view, the most important thing is to bring inflammatory arthritis under control as quickly as possible....This may also require use of some fairly strong medications, but it's important to recognize that they are necessary to reduce symptoms and prevent permanent damage.
...more severe cases may require more aggressive "second-line" medications, such as gold shots, sulfasalazine, or methotrexate.
Prevalence statistics for JA vary, but according to a 2008 report from the National Arthritis Data Workgroup,1 about 294,000 children age 0 to 17 are affected with arthritis or other rheumatic conditions.
DMARDs slow the progression of JA, but because they may take weeks or months to relieve symptoms, they often are taken with an NSAID. Although many different types of DMARDs are available, doctors are most likely to use one particular DMARD, methotrexate, for children with JA. Researchers have learned that methotrexate is safe and effective for some children with JA whose symptoms are not relieved by other medications.
Prevalence statistics for JA vary, but according to a 2008 report from the National Arthritis Data Workgroup,1 about 294,000 children age 0 to 17 are affected with arthritis or other rheumatic conditions.
Arthritis affects approximately one child in every 1,000 in a given year. Fortunately, most of these cases are mild. However, approximately one child in every 10,000 will have more severe arthritis that doesn't just go away.
From a doctor's point of view, the most important thing is to bring inflammatory arthritis under control as quickly as possible....This may also require use of some fairly strong medications, but it's important to recognize that they are necessary to reduce symptoms and prevent permanent damage.
...more severe cases may require more aggressive "second-line" medications, such as gold shots, sulfasalazine, or methotrexate.
DMARDs slow the progression of JA, but because they may take weeks or months to relieve symptoms, they often are taken with an NSAID. Although many different types of DMARDs are available, doctors are most likely to use one particular DMARD, methotrexate, for children with JA. Researchers have learned that methotrexate is safe and effective for some children with JA whose symptoms are not relieved by other medications.